Experts recommend SGLT-2 and GLP-1 only for adults at moderate to high risk of heart and kidney problems

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney complications, and in the majority of adults at moderate risk of complications, says a panel of international experts in The BMJ.

Facebook Comments